Company Profile
Updated: 26-OCT-09Arana Therapeutics Ltd.
International Private company
Level 2, 37 Epping Rd., Macquarie Park, NSW 2113, Australia
()61 02 8061 9900, 61 02 8061 9999 fax, http://www.arana.com
Primary SIC: Pharmaceutical Preparations, Primary NAICS: Pharmaceutical Preparation Manufacturing
Description: Manufacturing: Commercialisation of research, development, investment in and licensing of technology, and the formulation, manufacture and marketing of protein-based products for the pharmaceutical and veterinary industries
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
XOMA, COMV, CWCO, ANPI, WEL, MESA Expected To Be Lower After Earnings Releases on Monday.
M2 Presswire; 11/5/2009; 3477 words; ...Quarter Release Time XOMA XOMA Ltd. 12 quarters Q3 Before COMV Comverge...see if a pattern exists. XOMA Ltd. (NASDAQ: XOMA), a biopharmaceutical...Institute; Novartis AG; and Arana Therapeutics Limited. XOMA Ltd. was founded in 1981 and is headquartered...
Cephalon Spies New Anti-TNF Use in BDC Takeover: Sciatica.
BIOWORLD Today; 10/27/2009; 1245 words; ...gained the Phase II TNF inhibitor CEP-37247 (formerly ART-621) in the takeover of Arana Therapeutics Ltd., of Sydney, Australia, for $207 million. Arana became a wholly owned subsidiary of Cephalon in August, five months after the buyout...
Comprehsnsive Kyowa Hakko Report: Performance, Products, Pipeline and Potential.
M2 Presswire; 10/9/2009; 1211 words; ...Alcon Japan - Alnylam Pharmaceuticals - Amgen - Arana Therapeutics - Argos Therapeutics Inc - ArQule - Biogen Idec Inc - bioMAfA(c...perfo Source: Espicom Business Intelligence Ltd CONTACT: Laura Wood, Senior Manager, Research...
XOMA Announces $6 Million Antibody Discovery Collaboration.
Investrend; 9/14/2009; 1100 words; ...September 14, 2009 (FinancialWire) -- XOMA Ltd. (NASDAQ: XOMA) and Arana Therapeutics Ltd., a wholly-owned subsidiary of Cephalon...integrated information and data management systems. Arana has agreed to pay XOMA a fee of $6 million...
Financial Results of Arana Therapeutics Ltd versus Cyclopharm Ltd, Novogen Limited and Idt Australia Limited.
M2 Presswire; 8/14/2009; 977 words; ...Markets: Financial Results of Arana Therapeutics Ltd versus Cyclopharm Ltd, Novogen...s new companyprofile "Arana Therapeutics Ltd" to their offering. Quantitative...growth characteristics of Arana Therapeutics Ltd. There is a textual review...
Recent News Articles
- Financial Results of Arana Therapeutics Ltd versus Cyclopharm Ltd, Novogen Limited and Idt Australia Limited.
M2 Presswire - August 14, 2009 - Analyse a Textual Review of the Financial Results of Biota Holdings Limited versus Australia Limited, Arana Therapeutics Ltd and New Image Group Limited.
M2 Presswire - July 16, 2009 - Arana Therapeutics Limited - Therapeutic Competitors.
M2 Presswire - June 22, 2009 - Arana Therapeutics Limited - Financial and Strategic Analysis Review.
M2 Presswire - May 03, 2009
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning
